The potential of herbal drugs to treat heart failure:The roles of Sirt1/AMPK
10.1016/j.jpha.2023.09.001
- Author:
Zhang TAO
1
,
2
;
Xu LEI
;
Guo XIAOWEI
;
Tao HONGLIN
;
Liu YUE
;
Liu XIANFENG
;
Zhang YI
;
Meng XIANLI
Author Information
1. State Key Laboratory of Southwestern Chinese Medicine Resources,Innovative Institute of Chinese Medicine and Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu,611137,China
2. College of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu,611137,China
- Keywords:
Heart failure;
Silent information regulator 1;
Adenosine monophosphate-activated protein kinase;
Traditional Chinese medicine
- From:
Journal of Pharmaceutical Analysis
2024;14(2):157-176
- CountryChina
- Language:Chinese
-
Abstract:
Heart failure(HF)is a highly morbid syndrome that seriously affects the physical and mental health of patients and generates an enormous socio-economic burden.In addition to cardiac myocyte oxidative stress and apoptosis,which are considered mechanisms for the development of HF,alterations in cardiac energy metabolism and pathological autophagy also contribute to cardiac abnormalities and ultimately HF.Silent information regulator 1(Sirt1)and adenosine monophosphate-activated protein kinase(AMPK)are nicotinamide adenine dinucleotide(NAD+)-dependent deacetylases and phosphorylated kinases,respectively.They play similar roles in regulating some pathological processes of the heart through regulating targets such as peroxisome proliferator-activated receptor γ coactivator 1α(PGC-1α),protein 38 mitogen-activated protein kinase(p38 MAPK),peroxisome proliferator-activated receptors(PPARs),and mammalian target of rapamycin(mTOR).We summarized the synergistic effects of Sirt1 and AMPK in the heart,and listed the traditional Chinese medicine(TCM)that exhibit cardioprotective properties by modulating the Sirt1/AMPK pathway,to provide a basis for the development of Sirt1/AMPK activators or inhibitors for the treatment of HF and other cardiovascular diseases(CVDs).
